190 related articles for article (PubMed ID: 21713270)
1. Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter.
Yao Z; Yin P; Su D; Peng Z; Zhou L; Ma L; Guo W; Ma L; Xu G; Shi J; Jiao B
Mol Biosyst; 2011 Sep; 7(9):2608-14. PubMed ID: 21713270
[TBL] [Abstract][Full Text] [Related]
2. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
4. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
6. Expression and significance of IGF-1 and IGF-1R in thyroid nodules.
Liu YJ; Qiang W; Shi J; Lv SQ; Ji MJ; Shi BY
Endocrine; 2013 Aug; 44(1):158-64. PubMed ID: 23288662
[TBL] [Abstract][Full Text] [Related]
7. Papillary Thyroid Cancer and Coexisting Autoimmune Thyroiditis.
Veit F; Graf D; Momberger S; Helmich-Kapp B; Ruschenburg I; Peters A; Kussmann J; Saeger W; Schmidt KW; Toetsch M; Nestler K; Mann K
Horm Metab Res; 2017 Nov; 49(11):869-872. PubMed ID: 29136676
[TBL] [Abstract][Full Text] [Related]
8. Circulating miRNA95 and miRNA190 are sensitive markers for the differential diagnosis of thyroid nodules in a Caucasian population.
Cantara S; Pilli T; Sebastiani G; Cevenini G; Busonero G; Cardinale S; Dotta F; Pacini F
J Clin Endocrinol Metab; 2014 Nov; 99(11):4190-8. PubMed ID: 25057879
[TBL] [Abstract][Full Text] [Related]
9. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY
Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
[TBL] [Abstract][Full Text] [Related]
11. An antibody-like peptide that recognizes malignancy among thyroid nodules.
Reis CF; Carneiro AP; Vieira CU; Fujimura PT; Morari EC; Silva SJ; Goulart LR; Ward LS
Cancer Lett; 2013 Jul; 335(2):306-13. PubMed ID: 23462224
[TBL] [Abstract][Full Text] [Related]
12. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil to Lymphocyte Ratio is Useful in Differentiation of Malign and Benign Thyroid Nodules.
Sit M; Aktas G; Erkol H; Yaman S; Keyif F; Savli H
P R Health Sci J; 2019 Mar; 38(1):60-63. PubMed ID: 30924917
[TBL] [Abstract][Full Text] [Related]
14. T1 mapping and reduced field-of-view DWI at 3.0 T MRI for differentiation of thyroid papillary carcinoma from nodular goiter.
Yuan L; Zhao P; Lin X; Yu T; Diao R; Ning G
Clin Physiol Funct Imaging; 2023 May; 43(3):137-145. PubMed ID: 36440541
[TBL] [Abstract][Full Text] [Related]
15. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
Li M; Song Q; Li H; Lou Y; Wang L
PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
[TBL] [Abstract][Full Text] [Related]
17. Histiocytic aggregates in benign nodular goiters mimicking cytologic features of papillary thyroid carcinoma (PTC).
Nassar A; Gupta P; LiVolsi VA; Baloch Z
Diagn Cytopathol; 2003 Nov; 29(5):243-5. PubMed ID: 14595788
[TBL] [Abstract][Full Text] [Related]
18. 'Incidental' and 'non-incidental' thyroid papillary microcarcinomas are two different entities.
Provenzale MA; Fiore E; Ugolini C; Torregrossa L; Morganti R; Molinaro E; Miccoli P; Basolo F; Vitti P
Eur J Endocrinol; 2016 Jun; 174(6):813-20. PubMed ID: 27032694
[TBL] [Abstract][Full Text] [Related]
19. Correlation between serum lead and thyroid diseases: papillary thyroid carcinoma, nodular goiter, and thyroid adenoma.
Li H; Li X; Liu J; Jin L; Yang F; Wang J; Wang O; Gao Y
Int J Environ Health Res; 2017 Oct; 27(5):409-419. PubMed ID: 28891673
[TBL] [Abstract][Full Text] [Related]
20. The pathology of the nodular goiter.
LINDSAY S
Calif Med; 1949 Sep; 71(3):207. PubMed ID: 18137217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
